Genome-Wide DNA Methylation in Early-Onset-Dementia Patients Brain Tissue and Lymphoblastoid Cell Lines

Oscar Ramos-Campoy,Aina Comas-Albertí,David Hervás,Sergi Borrego-Écija,Beatriz Bosch,Juan Sandoval,Laura Fort-Aznar,Fermín Moreno-Izco,Guadalupe Fernández-Villullas,Laura Molina-Porcel,Mircea Balasa,Albert Lladó,Raquel Sánchez-Valle,Anna Antonell

DOI: https://doi.org/10.3390/ijms25105445

IF: 5.6

2024-05-17

International Journal of Molecular Sciences

Abstract:Epigenetics, a potential underlying pathogenic mechanism of neurodegenerative diseases, has been in the scope of several studies performed so far. However, there is a gap in regard to analyzing different forms of early-onset dementia and the use of Lymphoblastoid cell lines (LCLs). We performed a genome-wide DNA methylation analysis on sixty-four samples (from the prefrontal cortex and LCLs) including those taken from patients with early-onset forms of Alzheimer's disease (AD) and frontotemporal dementia (FTD) and healthy controls. A beta regression model and adjusted p-values were used to obtain differentially methylated positions (DMPs) via pairwise comparisons. A correlation analysis of DMP levels with Clariom D array gene expression data from the same cohort was also performed. The results showed hypermethylation as the most frequent finding in both tissues studied in the patient groups. Biological significance analysis revealed common pathways altered in AD and FTD patients, affecting neuron development, metabolism, signal transduction, and immune system pathways. These alterations were also found in LCL samples, suggesting the epigenetic changes might not be limited to the central nervous system. In the brain, CpG methylation presented an inverse correlation with gene expression, while in LCLs, we observed mainly a positive correlation. This study enhances our understanding of the biological pathways that are associated with neurodegeneration, describes differential methylation patterns, and suggests LCLs are a potential cell model for studying neurodegenerative diseases in earlier clinical phases than brain tissue.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the genome - wide DNA methylation patterns in brain tissues and lymphoblastoid cell lines of patients with early - onset dementia (including Alzheimer's disease and frontotemporal dementia), and analyze the differences in these patterns among different disease types and their biological significance. Specifically, the study aims to:

1. **Compare different types of early - onset dementia**: Study the genome - wide DNA methylation patterns in patients with early - onset Alzheimer's disease (EOAD) and early - onset frontotemporal dementia (FTD), as well as the differences between these patterns and those of the healthy control group.

2. **Use different sample types**: In addition to the prefrontal cortex tissue of the brain, lymphoblastoid cell lines (LCLs) are also used as samples to evaluate whether these cell lines can be used as alternative models for studying the early stages of neurodegenerative diseases.

3. **Analyze the relationship between methylation and gene expression**: Through correlation analysis, explore the relationship between DNA methylation levels and gene expression, especially whether there are consistent or different association patterns in the brain and LCLs.

4. **Identify common methylation sites**: Look for differentially methylated positions (DMPs) that are commonly present in patients with different types of early - onset dementia, and analyze the biological significance of these sites.

5. **Explore potential diagnostic markers**: Through machine - learning methods (such as the Elastic Net model), identify CpG sites that can distinguish different patient groups from the healthy control group, and evaluate their potential as diagnostic markers.

Through these research objectives, the paper aims to deepen the understanding of the biological mechanisms of early - onset dementia, especially from an epigenetic perspective, and provide new ideas for the early diagnosis and treatment of the disease.